Peter D Mcarthur, MD in Cleveland, MS - Otolaryngology

Peter D Mcarthur, MD is a Otolaryngology physician based in Cleveland, Mississippi. Peter D Mcarthur is licensed to practice in Mississippi (license number 17632) and his current practice location is 907 E Sunflower Rd, Cleveland, Mississippi. He can be reached at his office (for appointments etc.) via phone at (662) 843-8801.

NPI number for Peter D Mcarthur is 1073501458 and his current mailing address is 907 E Sunflower Rd, Cleveland, Mississippi. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1073501458.

Contact Information

	Peter D Mcarthur, MD
	907 E Sunflower Rd, Cleveland, MS 38732-2830
	(662) 843-8801
	Not Available

Physician's Profile

Full Name	Peter D Mcarthur
Gender	Male
Speciality	Otolaryngology
Location	907 E Sunflower Rd, Cleveland, Mississippi
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1073501458
Provider Enumeration Date: 10/11/2005
Last Update Date: 12/01/2007

Medical Identifiers

Medical identifiers for Peter D Mcarthur such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1073501458	NPI	-	NPPES
00126255	Medicaid	MS
1769681	Medicaid	LA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Y00000X	Otolaryngology	17632 (Mississippi)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Peter D Mcarthur is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Peter D Mcarthur, MD 907 E Sunflower Rd, Cleveland, MS 38732-2830 Ph: (662) 843-8801	Peter D Mcarthur, MD 907 E Sunflower Rd, Cleveland, MS 38732-2830 Ph: (662) 843-8801

News Archive

Positive top-line results from alemtuzumab Phase 3 trial on multiple sclerosis

Sanofi and its subsidiary Genzyme announced today positive top-line results from CARE-MS I, the first of two randomized, Phase 3 clinical trials comparing the investigational drug alemtuzumab to the approved multiple sclerosis therapy Rebif in patients with relapsing-remitting multiple sclerosis.

When a patient wishes to leave against medical advice - ethical dilemma for physicians

When patients choose to leave the hospital before the treating physician recommends discharge, the consequences may involve risk of inadequately treated medical conditions and the need for readmission, according to a review in the March 2009 issue of Mayo Clinic Proceedings.

Pollution can contribute to the development of cardiovascular diseases

Journal of the American Heart Association reports that exposure to air pollution can contribute to the development of cardiovascular diseases.

NSF to hold Sleep Health & Safety conference in Washington

The National Sleep Foundation (NSF) will hold its annual Sleep Health & Safety conference March 2-3, 2012 at the JW Marriott in Washington, DC.

Peter D Mcarthur, MD - Otolaryngology in Cleveland, MS